CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Open-market sale Chief Financial Officer sold 13,583 shares at an average $35.46 ($481,621)
- 4 Open-market sale General Counsel sold 2,000 shares at an average $35.88 ($71,750)
- 4 Open-market sale Chief Scientific Officer sold 800 shares at an average $36.27 ($29,018)
- 4 Open-market sale Chief Business Officer sold 15,000 shares at an average $35.49 ($532,352)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 914,216 shares (other)
- 4 Exercise or conversion Chief Scientific Officer acquired 12,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 784,313 shares (conversion)
- 4 Conversion 10% owner acquired 1,176,470 shares (conversion)
- 4 Conversion 10% owner acquired 6,672,548 shares (conversion)
- 4 Conversion 10% owner acquired 6,672,548 shares (conversion)
- 4 Conversion 10% owner acquired 5,422,549 shares (conversion)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 14 · 274 filings